Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Acquiring Remaining Share of PerkinElmer India, Plans More Regional Growth

NEW YORK (GenomeWeb News) — PerkinElmer yesterday said it has acquired the remaining interest in PerkinElmer India from Labindia Instruments for an undisclosed sum.
 
The company also said it plans to open a new headquarters and a new technical support and applications center in Mumbai later this year.
 
PerkinElmer India is a sales, service, and marketing branch aimed at India’s biotechnology sector. The acquisition makes PerkinElmer India a wholly owned PerkinElmer subsidiary, the company said.
  
PerkinElmer CEO Gregory Summe said this deal shows the company’s commitment “to accelerate growth in the country’s rapidly expanding health sciences market.”
 
PerkinElmer India currently employs 170 people.
 
Financial terms of the deal were not disclosed.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.